CompaniesBioSense Technologies

BioSense Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

5

As Collaborator

1

Total Enrollment

234

By Phase

NA: 5PHASE2/PHASE3: 1

By Status

UNKNOWN: 3TERMINATED: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02393391
NCT02740062
Hover over trial bars to see details

Recent Trials

NCT06616012Lead Sponsor
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal IntensiVE Care Patients -3
NAEnrolling by invitation
50 participants
Started: Sep 14, 2023 · Completed: Mar 30, 2025
NCT05433779Lead Sponsor
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2
NATerminated
8 participants
Started: Dec 15, 2022 · Completed: Jun 16, 2023
NCT03967587Lead Sponsor
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients
NATerminated
6 participants
Started: Nov 19, 2020 · Completed: Mar 6, 2021
NCT02740062Lead Sponsor
Non Invasive Brain Evaluation and Treatment for Neuropathic Pain
NAUnknown
30 participants
Started: Mar 31, 2016
NCT02615418Lead Sponsor
Non Invasive Brain Stimulation Treatment for CLBP
NAUnknown
60 participants
Started: Jan 31, 2016 · Completed: Jul 31, 2017
View all 6 trials →